Two Doses of BNT162b2 mRNA Vaccine in Patients after Hematopoietic Stem Cell Transplantation: Humoral Response and Serological Conversion Predictors.

Cancers (Basel) · 2022 · PMC8773492 · PMID 35053487

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

When patients were categorized according to ongoing treatment with calcineurin inhibitor (CNI) at the time of vaccination, the difference in antibody concentration was also highly significant. 3.5.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.